PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29788500-12	2018	CD47 activation likely disrupts nitric oxide ( NO) signaling and promotes leukocyte-endothelial interactions.	Nitric Oxide	32-44	CD47 molecule	Homo sapiens	0-4	
34205047-2	2021	Moreover, TSP1/CD47 interaction has been found to be associated with platelet hyperaggregability and impaired nitric oxide response, exacerbating progression in IRI and PAH.	Nitric Oxide	110-122	CD47 molecule	Homo sapiens	15-19	
29979224-17	2018	Furthermore, we identified direct targeting of CD47 by microRNA-155 as a novel mechanism of myocardial and vascular contractile depression in sepsis, promoting microvascular endothelial cell and vascular insensitivity to thrombospondin-1-mediated inhibition of nitric oxide production and nitric oxide-mediated vasorelaxation, respectively.	Nitric Oxide	261-273	CD47 molecule	Homo sapiens	47-51	
29979224-17	2018	Furthermore, we identified direct targeting of CD47 by microRNA-155 as a novel mechanism of myocardial and vascular contractile depression in sepsis, promoting microvascular endothelial cell and vascular insensitivity to thrombospondin-1-mediated inhibition of nitric oxide production and nitric oxide-mediated vasorelaxation, respectively.	Nitric Oxide	289-301	CD47 molecule	Homo sapiens	47-51	
20923780-8	2010	These results reveal that anti-angiogenic signaling through CD47 is highly redundant and extends beyond inhibition of nitric oxide signaling to global inhibition of VEGFR2 signaling.	Nitric Oxide	118-130	CD47 molecule	Homo sapiens	60-64	
25482981-3	2015	We investigated whether blocking the CD47/thrombospondin-1 inhibitory action on nitric oxide signaling with a monoclonal antibody specific to CD47 (CD47mAb400) would reduce IRI in liver grafts.	Nitric Oxide	80-92	CD47 molecule	Homo sapiens	37-41	
25482981-3	2015	We investigated whether blocking the CD47/thrombospondin-1 inhibitory action on nitric oxide signaling with a monoclonal antibody specific to CD47 (CD47mAb400) would reduce IRI in liver grafts.	Nitric Oxide	80-92	CD47 molecule	Homo sapiens	142-146	
25482981-3	2015	We investigated whether blocking the CD47/thrombospondin-1 inhibitory action on nitric oxide signaling with a monoclonal antibody specific to CD47 (CD47mAb400) would reduce IRI in liver grafts.	Nitric Oxide	80-92	CD47 molecule	Homo sapiens	148-158	
27331362-3	2016	Steatotic livers are more susceptible to ischemia-reperfusion injury (IRI), which is exacerbated by the thrombospondin-1/CD47 pathway through inhibition of nitric oxide signaling.	Nitric Oxide	156-168	CD47 molecule	Homo sapiens	121-125	
18187671-3	2008	The recent discovery that thrombospondin-1 acts via CD47 to inhibit nitric oxide signaling throughout the vascular system has given new importance and perhaps a unifying mechanism of action to these enigmatic proteins.	Nitric Oxide	68-80	CD47 molecule	Homo sapiens	52-56